14 May 2018 Eric Van Cutsem et. al, Phase I/II trial of pimasertib plus gemcitabine in patients with metastatic pancreatic cancer. CONDIVIDI SU FacebookX Authors Eric Van Cutsem Products Response Request information Please insert your email address below, we will contact you soon. I confirm that I have read the information on the personal data management. I agree to the processing of my personal data according to the above mentioned information *Both options must be selected × Diatech Pharmacogenetics2018-05-14T15:40:11+02:00